Streetbeat News

Equity Actions

PLUG

Plug Power CEO Andy Marsh appeared on CNBC to discuss the company's projections and the day's stock movement following revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 6:53 pm

LRCX

A significant investor has taken a bearish stance on Lam Research (NASDAQ:LRCX), with 63% of recent trades being bearish. The targeted price range for Lam Research over the last 3 months is $530.0 to $645.0. The current price of LRCX is up 0.72% at $638.94. Wolfe Research has downgraded its action to Outperform with a price target of $825, while UBS maintains their Buy rating with a price target of $725.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:46 pm

ABBV

A significant bearish stance has been taken on AbbVie (NYSE:ABBV) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 8% bullish and 91% bearish. The whales have been targeting a price range from $55.0 to $150.0 for AbbVie over the last 3 months. Morgan Stanley maintains an Overweight rating on AbbVie with a price target of $193, while Raymond James downgraded its action to Outperform with a price target of $177.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:46 pm

EL

Estee Lauder Cos Inc. (NYSE:EL) has seen a 0.47% increase in the current market session, but an 8.52% decrease over the past month and a 34.63% decrease over the past year. The company's P/E ratio of 50.42 is higher than the Personal Products industry average of 36.93, which could indicate that the stock is overvalued or that it might perform better than its industry group.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:30 pm

DELL

Investor Business Daily's SwingTrader has reportedly purchased Dell Technologies' stock, according to traders' discussions.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 6:25 pm

MRMD

MariMed Inc. (OTC:MRMD) has expanded its retail footprint with the opening of an adult-use Thrive dispensary in Casey, Illinois. This is the fifth dispensary in Illinois and the 12th in MariMed’s portfolio across five states. The company also plans to commence operations at its processing facility in Mt. Vernon, Illinois in the fourth quarter, and anticipates the completion of its cultivation facility in early 2024. MariMed operates five of the state’s 130 licensed cannabis dispensary locations.

Portfolio Pulse from The Dales Report

October 11, 2023 | 6:20 pm

EIS

SPY

VGK

White House's Kirby has stated that the ability to support Israel and Ukraine using existing appropriations is running out. This could potentially impact the financial markets and specific ETFs related to these regions.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 6:19 pm

EIS

TSLA

UBS

As the conflict between Israel and Hamas escalates, Israel has formed a wartime cabinet and is preparing for a ground offensive in Gaza. The U.S. has pledged support to Israel, with a plane carrying ammunition landing in the country. ETFs investing in Israeli stocks, such as BlackRock's Ishares Msci Israel ETF (NYSE:EIS), are experiencing substantial outflows. UBS Group (NYSE:UBS) has postponed all business travel to the Middle East due to the conflict. Tesla (NASDAQ:TSLA) CEO Elon Musk announced that all Tesla-branded charging stations in Israel would be free.

Portfolio Pulse from Anthony Noto

October 11, 2023 | 6:08 pm

HES

A significant bullish stance has been taken on Hess (NYSE:HES) by a large investor, as indicated by a large position in the company's options. The sentiment among these big-money traders is 60% bullish and 40% bearish. The whales have been targeting a price range from $135.0 to $190.0 for Hess over the last 3 months. Analysts from UBS, Morgan Stanley, Piper Sandler, and Mizuho have maintained their positive ratings on Hess with price targets ranging from $166 to $210.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:01 pm

CRWD

A large bearish position on CrowdStrike Holdings (NASDAQ:CRWD) has been noticed, with 71% of big-money traders being bearish. The whales have been targeting a price range from $140.0 to $250.0 for CrowdStrike Holdings over the last 3 months. The price of CRWD is up 1.3% at $186.24. Wedbush, Scotiabank, Goldman Sachs, Jefferies, and Macquarie have maintained their ratings on CrowdStrike Holdings.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:01 pm